HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancerJie Xu, Rui Chen, Qingtao Meng et al.|Cell Death and Disease|2021Cited by 64
Investigation of the enhanced antitumour potency of CD46-specific chimeric antigen receptor-T cells in human colorectal cancer liver metastases after combination with nanotherapeuticsQingtao Meng, Rui Chen, Jie Xu et al.|Nano Today|2023Cited by 6
Supplementary Figure S1,Figure S2,Figure S3,Table S1，Table S2，Table S3，and Table S4. from <i>MPO</i> Promoter Polymorphism rs2333227 Enhances Malignant Phenotypes of Colorectal Cancer by Altering the Binding Affinity of AP-2αQingtao Meng, Rui Chen, Yajie Wang et al.|Unknown|2023Cited by 0
Data from <i>MPO</i> Promoter Polymorphism rs2333227 Enhances Malignant Phenotypes of Colorectal Cancer by Altering the Binding Affinity of AP-2αQingtao Meng, Rui Chen, Shenshen Wu et al.|Unknown|2023Cited by 0
Supplementary Figure S1,Figure S2,Figure S3,Table S1，Table S2，Table S3，and Table S4. from <i>MPO</i> Promoter Polymorphism rs2333227 Enhances Malignant Phenotypes of Colorectal Cancer by Altering the Binding Affinity of AP-2αQingtao Meng, Rui Chen, Shenshen Wu et al.|Unknown|2023Cited by 0